Trials / Withdrawn
WithdrawnNCT03748719
Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer
A Single Arm Phase II Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study involves Stereotactic Body Radiation Therapy (SBRT) followed by prostatectomy (removal of the prostate). SBRT is a relatively new radiation technique in which a few doses of radiation are delivered to small, well-defined tumors. It has been used effectively in other cancers like lung and liver. The radiation will be given for only 5 days. The purpose of this study is to compare the effects, good and/or bad, of different doses of SBRT given before prostatectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stereotactic Body Radiation Therapy (SBRT) | SBRT treatment |
Timeline
- Start date
- 2018-11-19
- Primary completion
- 2019-10-15
- Completion
- 2019-12-04
- First posted
- 2018-11-21
- Last updated
- 2020-05-22
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03748719. Inclusion in this directory is not an endorsement.